Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience

Movement Disorders

Volumn 13, Issue 3, 1998, Pages 377-382

  Trosch, Richard M ^a,e   Friedman, Joseph H ^b   Lannon, Meg C ^b   Pahwa, Rajesh ^c   Smith, D ^c   Seeberger, Lauren C ^d   O'Brien, Christopher F ^d   LeWitt, Peter A ^a   Koller, William C ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d Colorado Neurological Institute ^*  (United States)

^e Clinical Neuroscience Center   (United States)

Author keywords

Akathisia; Clozapine; Depression; Pain; Parkinson's disease; Psychosis

Indexed keywords

CLOZAPINE;

ADULT; AGED; AKATHISIA; AMNESIA; ANXIETY; ARTICLE; COGNITIVE DEFECT; DEPRESSION; DROWSINESS; DYSTONIA; FEMALE; HUMAN; HYPERSALIVATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; SEXUAL DYSFUNCTION; SLEEP DISORDER; TORTICOLLIS; TREATMENT FAILURE; TREMOR;

AGED; AMBULATORY CARE; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PATIENT ADMISSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031919315     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130302     Document Type: Article

References (37)

1. Factor SA, Friedman JH. The emerging role of clozapine in the treatment of movement disorders. Mov Disord. 1997;12:483-496.
2. Scholz E, Dichgens J. Treatment of drug induced exogenous psychosis in parkinsonism with clozapine and fluperlapine. Eur Arch Psychiatry Neurol Sci 1985;235:60-64.
3. Ostergaard K, Dupont E. Clozapine treatment of drug induced psychotic symptoms in later stages of Parkinson's disease. Acta Neurol Scand 1988;78:349-350.
4. Friedman JH, Lannon MC. Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 1989;39:1219-1221.
5. Wolters E, Hurwitz TA, Peppaard RF, Calne DB. Clozapine: an antipsychotic agent for Parkinson's disease? Clin Neuropharmacol 1989;12:83-90.
6. Greene P, Coté L, Fahn S. Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Adv Neurol 1993;60:703-706.
7. Wolk SI, Douglas CJ. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases. J Clin Psychiatry 1992;53:373-376.
8. Bear J, Lawson W, Burns S, Tarke U. Clozapine in idiopathic Parkinson's. Biol Psychiatry 1989;25:163A.
9. Rosenthal SH, Fenton ML, Harnett DS. Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease. Gen Hosp Psychiatry 1992;14:285-286.
10. Rabey JM, Trevas TA, Orlov E, Katy T, Korczyn AD. Low dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease. Neurology 1995;455:432-434.
11. Chacko RC, Hurley RA, Harper RG, Jankovic J, Cardoso F. Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1995;7:471-475.
12. Wolters EC, Hurwitz RE, Mak E, et al. Clozapine in the treatment of parkinsonian patients with dopaminergic psychosis. Neurology 1990;40:832-834.
13. Friedman JH, Max J, Swift R. Idiopathic Parkinson's disease in a chronic schizophrenic patient; long term treatment with clozapine and L-dopa. Clin Neuropharmacol 1987;10:470-475.
14. Factor SA, Brown D, Molho ES, Podskalny GD. Clozapine: a two year open trial in Parkinson's disease patients with psychosis. Neurology 1994;44:544-546.
15. Pfeiffer RF, Kang J, Graber B, Hofman R, Wilson J. Clozapine for psychosis in Parkinson's disease. Mov Disord 1990;5:239-242.
16. Lew MF, Waters C. Clozapine treatment of parkinsonism with psychosis. J Am Geriatr Soc 1993;41:669-671.
17. Roberts HE, Dean RC, Stoudemire A. Clozapine treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1989;1:190-192.
18. Pinter MM, Helscher RJ. Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease. J Neural Transm Park Dis Dement Sect 1991;5:135-146.
19. Kahn N, Freeman A, Juncos JL, Manning D, Watts RL. Clozapine is beneficial for psychosis in Parkinson's disease. Neurology 1991; 40:1151-1700.
20. Linazasaro G, Marti-Masso JF, Suarez JA. Nocturnal akathisia in Parkinson's disease: treatment with clozapine. Mov Disord 1993; 8:171-174.
21. Pakkenberg H, Pakkenberg B. Clozapine in the treatment of tremor. Acta Neurol Scand 1986;73:295-297.
22. Friedman JH, Lannon MC. Clozapine treatment of tremor in Parkinson's disease. Mov Disord 1990;5:225-229.
23. Jansen ENH. Clozapine in the treatment of tremor in Parkinson's disease. Acta Neurol Scand 1994;89:262-265.
24. Fischer PA, Baas H, Hefner R. Treatment of parkinsonian tremor with clozapine. J Neural Transm 1990;2:230-238.
25. Bennett JP, Landow ER, Schuh LA. Suppression of dyskinesias in advanced Parkinson's disease. II: Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms. Neurology 1993;43:1551-1555.
26. Bennett JP, Landow ER, Dietrich S, Schuh LA. Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesias reduction. Mov Disord 1994;4:409-414.
27. VanToi HH, Bunzow JR, Guan HC. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991;350:610-614.
28. Baldessarini RJ, Frankenburg FR. Drug therapy: clozapine - a novel antipsychotic agent. N Engl J Med 1991;324:746-754.
29. Bartholini G, Haefly W, Jalfre M, et al. Effects of clozapine on cerebral catecholaminergic neuron systems. Br J Pharmacol 1972; 46:736-740.
30. Parsa MA, Ramirez LF, Loula EC, Meltzer HY. Effect of clozapine on psychotic depression and parkinsonism. J Clin Psychopharmacol 1991;11:330-331.
31. Quinn NP, Toone B, Lang AE. Dopa dose-dependent sexual deviation. Br J Psychiatry 1983;142:296-298.
32. Van Putten T, Wirshing WS, Marder SR. Tardive Meige syndrome responsive to clozapine. J Clin Psychopharmacol 1990;10:381-382.
33. Trugman JM, Leadbetter R, Zalis ME, et al. Treatment of severe axial tardive dystonia with clozapine. Case report and hypothesis. Mov Disord 1994;9:441-446.
34. Trosch RM, Friedman JH, LeWitt PA. Clozapine treatment of dystonia in Parkinson's disease [Abstract]. Mov Disord 1994; 9(suppl 1):102.
35. Meltzer HY. The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychiatry 1992;160(suppl 2):22-29.
36. Arevalo GJG, Gershanik OS. Modulatory effect of clozapine on levodopa response in Parkinson's disease: a preliminary study. Mov Disord 1993;8:349-354.
37. Nutt JG, Gancher ST, Woodward WR. Does an inhibitory action of levodopa contribute to motor fluctuations? Neurology 1988;38: 1553-1557.